Advanced Biomed Inc Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Advanced Biomed Inc (ADVB) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$151.82 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-05-15
- Advanced Biomed Inc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-09-30 was -$82.75K.
- Advanced Biomed Inc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-09-30 was -$303.85K.
- Advanced Biomed Inc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $218.35K, a 31.62% decline from fiscal 2024.
- Advanced Biomed Inc effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was $319.32K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | -$151.82K 10-Q · filed 2026-05-15 | |||||
| 2025-12-31 | -$122.62K 10-Q · filed 2026-02-13 | |||||
| 2025-09-30 | -$82.75K 10-Q · filed 2025-11-19 | |||||
| 2025-06-30 | $218.35K 10-K · filed 2025-10-08 | |||||
| 2025-03-31 | $138.00K 10-Q · filed 2026-05-15 | $168.95K 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | $63.70K 10-Q · filed 2026-02-13 | $129.26K 10-Q · filed 2025-04-15 | ||||
| 2024-09-30 | -$303.85K 10-Q · filed 2025-11-19 | |||||
| 2024-06-30 | $319.32K 10-K · filed 2025-10-08 | |||||
| 2024-03-31 | $169.51K 10-Q · filed 2025-05-15 | |||||
| 2023-12-31 | -$194.34K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |